EMA committee recommends approval of Eisai & Biogen’s lecanemab to treat early Alzheimer’s disease: Tokyo Saturday, November 16, 2024, 13:00 Hrs [IST] Eisai Co., Ltd. and Biog ...
Lecanemab is the first treatment for Alzheimer’s disease licensed for use in Great Britain that shows some evidence of ...
and are at increased risk of developing Alzheimer’s disease. Those with one copy are at increased risk too. Leqembi, which is ...
Denali Therapeutics' innovative approach to neurological disorders and strong financial strategy position it as a leader in ...
Venturi Wealth Management LLC raised its stake in Biogen Inc. (NASDAQ:BIIB – Free Report) by 73.8% in the 3rd quarter, ...
Los Angeles Capital Management LLC bought a new stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) in the third ...
GRAND JUNCTION, Colo. ( KREX) – A head-on collision affected traffic Friday night at North Avenue and 12th Street. Around ...
Energy Secretary Ed Miliband is expected to scale back plans for 'hidden tax' on new boilers amid the backlash to Chancellor Rachel Reeves' debut Budget ...